FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas.

FBXO11 is identified as the F-box protein that normally targets BCL6 for degradation, and FBXO11 deletions or mutations that prevent this function and thus stabilize BCL6 are found in B-cell lymphomas.